Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 9, 2017New Devices Combine Longest-Lasting Battery Technology, Therapy Optimization and HeartLogic™ Heart Failure Diagnostics
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Resonate™ family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization...
-
May 3, 2017Late-Breaking Clinical Trials Feature Subcutaneous Implantable Defibrillator and WATCHMAN™ Left Atrial Appendage Closure Device
Boston Scientific (NYSE: BSX) today announced the schedule of key data presentations, including two late-breaking clinical trials, that will be featured at the 38th Annual Scientific Sessions of...
-
May 1, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2017 Healthcare Conference on Thursday, May 18, 2017 in Las Vegas. Susie Lisa, vice...
-
Apr 27, 2017
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.160 billion during the first quarter ended March 31, 2017. This represents growth of 10 percent compared to the prior year period on...
-
Apr 18, 2017MADIT S-ICD Trial to Study EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System; Trial Recruitment Part of Pilot Initiative to Increase Percentage of Females Enrolled in Clinical Studies
Boston Scientific (NYSE: BSX) has initiated a worldwide study that will evaluate the survival benefit of patients treated with the EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD)...
-
Mar 30, 2017
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2017 on Thursday, April 27,...
-
Mar 30, 2017Acquisition Will Expand Treatments for Patients with Valvular Heart Disease and Strengthen Company's Position in Structural Heart Globally
Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter...
-
Mar 16, 2017Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; has potential for significant cost savings
Today, the National Institute for Health and Care Excellence (NICE) issued medical technology guidance recommending the use of Boston Scientific Corporation (NYSE: BSX) cardiac resynchronization...
-
Mar 9, 2017Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K.
Boston Scientific Corporation (NYSE: BSX) today announced the German District Court of Düsseldorf has determined that Edwards Lifesciences Corporation and its German subsidiary's Sapien 3™...
-
Mar 7, 2017
Boston Scientific Corporation (NYSE: BSX) will participate in the Barclays Global Healthcare Conference on March 15 in Miami Beach, Florida. Mike Mahoney, chairman and chief executive officer, and...
-
Mar 3, 2017Finalists will present their ideas to a panel of judges and a live audience in Cambridge on March 9; Top winners will be awarded up to $50,000 of in-kind support to advance submitted concept
Boston Scientific Corporation (NYSE: BSX) today announced six finalists in its second annual Connected Patient Challenge, an open competition focused on turning big data into actionable...
-
Feb 21, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Cowen and Company 37th Annual Healthcare Conference on Tuesday, March 7, 2017 in Boston. Dan Brennan, executive vice...
-
Feb 15, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2017 RBC Capital Markets Global Healthcare Conference on Thursday, February 23, 2017 in New York. Dan Brennan,...
-
Feb 2, 2017
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.191 billion during the fourth quarter ended December 31, 2016. This represents growth of 11 percent compared to the prior year...
-
Feb 1, 2017
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the LEERINK Partners 6th Annual Global Healthcare Conference on February 15, in New York. Susie Lisa, vice president,...
-
Jan 3, 2017
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter ended December 31, 2016 on Thursday, February 2, 2017, at 8:00 a.m....
-
Dec 30, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 in San Francisco. Mike Mahoney, chairman and...
-
Dec 13, 2016
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of certain manufacturing assets and capabilities of the Neovasc, Inc., (NASDAQ: NVCN) (TSX: NVC) advanced...
-
Dec 5, 2016Third consecutive “Best Places to Work for LGBT Equality” award
MARLBOROUGH, Mass., December 5, 2016 — Boston Scientific (NYSE: BSX) has been recognized for the third consecutive year as a “Best Place to Work” by the Human Rights Campaign Foundation. The...
-
Dec 2, 2016‒ $75M transaction enhances manufacturing expertise in structural heart
Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire certain manufacturing assets and capabilities of the Neovasc, Inc., (NASDAQ: NVCN) (TSX: NVC) advanced...
-
Nov 23, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Citi 2016 Global Healthcare Conference on December 7 in New York City. Dan Brennan, executive vice president & chief...
-
Nov 22, 2016Acquisition Expands Endoscopy Portfolio
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of EndoChoice Holdings, Inc. (NYSE: GI). With the completion of the acquisition, EndoChoice will become part...
-
Nov 21, 2016
Boston Scientific today announced that its Cork, Ireland manufacturing facility has received the 2016 Shingo Prize for Excellence in Manufacturing from the Shingo Institute, part of the Jon M....
-
Nov 16, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 28th Annual Piper Jaffray Healthcare Conference on November 29 in New York City. Jeff Mirviss, senior vice president &...
-
Nov 16, 2016Late-Breaking Trial Data Presented at AHA Scientific Sessions Demonstrate Success of Alert to Predict Worsening Heart Failure
Boston Scientific (NYSE: BSX) today announced results from the first clinical trial evaluating the performance of the HeartLogic™ Heart Failure Diagnostic Service to predict impending heart...